# Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

> **NCT00978341** · NA · TERMINATED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 15 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Placebo for pregabalin

## Key facts

- **NCT ID:** NCT00978341
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** See Detailed Description
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978341, "Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00978341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*